INTRODUCTION {#sec1-1}
============

Periodontal regeneration is defined as reproduction or reconstitution of lost or injured part.\[[@ref1]\] Currently, procedures that are used in periodontal regeneration offer limited potential toward attaining complete periodontal restoration.

In 1971, Robert Marx showed evidence that platelets are reservoirs of growth factors and cytokines which are the key factors for bone and soft-tissue regeneration.\[[@ref2][@ref3][@ref4][@ref5]\] Choukroun in 2001\[[@ref6]\] prepared a second-generation platelet concentrate (platelet-rich fibrin \[PRF\]) which contains growth factors.\[[@ref7][@ref8]\] PRF clot forms a strong natural fibrin matrix which provides rapid wound healing.\[[@ref9]\]

Despite many clinical trials, there is still a concern about health hazards of silica containing glass tubes used for the collection of blood for PRF.\[[@ref10]\] Considering this, biocompatible titanium tubes were used for the preparation of titanium-prepared PRF (T-PRF) by Tunalı in 2013.\[[@ref11]\] T-PRF is a platelet and leukocyte-rich fibrin similar to that obtained from classical PRF method. Histologically, T-PRF and PRF are almost similar.\[[@ref12]\]

Numerous studies have proven the regenerative efficacy of PRF. However, there is limited literature on the clinical efficacy and histologic picture of T-PRF. Hence, this study was initiated.

MATERIALS AND METHODS {#sec1-2}
=====================

A randomized split-mouth study was conducted in the department of periodontology. Ethical clearance was obtained from institutional review board. Ten patients were recruited from the outpatient department.

Twenty sites were selected using a random sequence method and categorized as:

Group A (Test group) -- 10 sites (T-PRF)Group B (Control group) -- 10 sites (PRF).

Verbal/written consent was taken. After Phase I therapy, patients were re-evaluated after 4 weeks. Patients with pocket depth ≥5 mm, with 2 or more pockets with three-walled defects, on both the sides, were included in the study.

Clinical evaluation was done presurgically \[[Figure 1](#F1){ref-type="fig"}\], and at intervals of 3 months and 9 months' postoperatively.

![Probing depth at baseline of test group](JISP-23-554-g001){#F1}

The following clinical parameters were evaluated:

Gingival index\[[@ref13]\]Plaque index\[[@ref14]\]Probing pocket depth (PPD)Relative attachment level (RAL).\[[@ref15]\]

Inclusion criteria {#sec2-1}
------------------

### Patients {#sec3-1}

In the age group of 35--55 yearsMaintaining proper oral hygieneSystemically healthyPocket depth ≥5 mmm.

Exclusion criteria {#sec2-2}
------------------

Pregnant and lactating femalesConsuming tobacco in any formWho have undergone periodontal surgical therapy in the past 6 monthsWho have received antibiotic therapy in the previous 3 months.

Surgical procedure {#sec2-3}
------------------

### Flap preparation {#sec3-2}

A full thickness mucoperiosteal flap was reflected exposing 1--2 mm of healthy bone.

### Defect preparation {#sec3-3}

The defect was thoroughly debrided \[[Figure 2](#F2){ref-type="fig"}\]. T-PRF was prepared \[[Figure 3](#F3){ref-type="fig"}\]. T-PRF was placed in the defect and covered by T-PRF membrane in the test sites \[[Figure 4](#F4){ref-type="fig"}\]. The T-PRF clot was cut longitudinally into two parts -- one used as a graft and the second part as a membrane with the red blood cell (RBC) end of the membrane facing the defect like guided tissue regeneration (GTR). suturing was done \[[Figure 5](#F5){ref-type="fig"}\].

![Incision, reflection, and debridement done. Postdebridement exposing the defect site (test group)](JISP-23-554-g002){#F2}

![Preparation of titanium-prepared platelet-rich fibrin following centrifugation (test group)](JISP-23-554-g003){#F3}

![Placement of titanium-prepared platelet-rich fibrin as a Graft and membrane over the grafted site (test group)](JISP-23-554-g004){#F4}

![Interrupted sutures given using 4-0 silk suture (test group)](JISP-23-554-g005){#F5}

Coe-Pack was placed \[[Figure 6](#F6){ref-type="fig"}\]. Postoperative instructions were given. Patients were prescribed antibiotics, analgesics, and 0.2% chlorhexidine mouthwash twice daily for 14 days. Patients were recalled at 3 and 9 months \[Figures [7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"}\]. Intraoral periapical radiographs were taken with paralleling technique and a radiographic grid of 1 mm2 framework on an intraoral periapical X-ray film. Grid measurement of infrabony defect on radiograph was measured using digital vernier caliper and divider set. Radiographic evaluation (i.e., defect depth) was done presurgically at baseline \[[Figure 9](#F9){ref-type="fig"}\] and at 9 months' postoperatively, for T-PRF \[[Figure 10](#F10){ref-type="fig"}\]. Similar study design was used for PRF \[Figures [11](#F11){ref-type="fig"}--[16](#F16){ref-type="fig"}\].

![Placement of periodontal dressing (test group)](JISP-23-554-g006){#F6}

![Probing depth after 3 months of test site](JISP-23-554-g007){#F7}

![Probing depth after 9 months shows a reduction in the pocket probing depth (test site)](JISP-23-554-g008){#F8}

![Baseline preoperative radiograph of defect site of test group](JISP-23-554-g009){#F9}

![9 months' postoperative radiograph showed increase in the height of alveolar bone (test group)](JISP-23-554-g010){#F10}

![Probing depth at baseline for control group](JISP-23-554-g011){#F11}

![Placement of platelet-rich fibrin in the defect site (control site)](JISP-23-554-g012){#F12}

![Probing depth after 3 months for control group](JISP-23-554-g013){#F13}

![Probing depth after 9 months for control group](JISP-23-554-g014){#F14}

![Baseline preoperative radiograph of defect site of control group](JISP-23-554-g015){#F15}

![Nine months' postoperative radiograph of defect site of control group](JISP-23-554-g016){#F16}

For the *in vitro* study, the fibrin clots derived after centrifugation was used for light microscopy and scanning electron microscopy analysis.

Histological procedures for light microscopy\[[@ref16]\] {#sec2-4}
--------------------------------------------------------

The T-PRF and PRF clots were fixed in 10% neutrally buffered formalin for 24 h at room temperature followed by dehydration in increasing gradients of alcohol (70%, 95%, and 100%). They were then placed in xylene before paraffin inclusion. Successive sections of 4 μ were performed along the center of the long axis of clots and then stained with hematoxylin and eosin. They were viewed in ×40 magnification under a light microscope.

Histological procedure for scanning electron microscopy\[[@ref16]\] {#sec2-5}
-------------------------------------------------------------------

The morphologic evaluation of the T-PRF and PRF clots was conducted with a scanning electron microscope (QUANTA 400). The clots were fixed in 2.5% glutaraldehyde for 24 h and treated for gradual desiccation and subsequently examined under a scanning electron microscope. Photographs were taken at 20 kV using a magnification from ×2000.

### Platelet-rich fibrin preparation protocol {#sec3-4}

During surgery, 9 ml of blood was collected from antecubital vein in a plain vacutainer tube and immediately centrifuged at 3000 rpm for 10 min, at room temperature in a table-top centrifuge, REMI-R4C.\[[@ref4]\]

### Titanium-prepared platelet-rich fibrin preparation protocol {#sec3-5}

Using a similar protocol, titanium tubes were used to procure T-PRF at 2800 rpm for 12 min.\[[@ref16]\]

Defect depth {#sec2-6}
------------

Occlusal stents were made with acrylic and ligature wire, and a round metal ball was inserted into it. It provided a fixed reference point and fixed angulations for the clinical measurements of the infrabony defects. The ball used in stent acted as a guidance for the measurement of defect depth radiographically.\[[@ref17]\]

Statistical analysis {#sec2-7}
--------------------

Data analysis was done using Windows-based "MedCalc Statistical Software" Version 17.8.2 (MedCalcSoftware, Ostend, Belgium; [http://www.medcalc.org; 2017](http://www.medcalc.org;2017)). Data analysis was done *P* \< 0.05 was taken for statistical significance.

The software for the calculations used was G Power 3.0.10 software. The α error was set at 5% with the power of the study at 80%.

Measurement data for probing depth, RAL, plaque index, gingival index, and defect depth are expressed as means with standard deviation and standard error of mean. Ninety-five percent confidence intervals are also presented as applicable for the mean values. Change from baseline data is presented as means with percentage means. Data for all parameters were tested using Shapiro--Wilk test for normal distribution. *P* \< 0.05 was taken for statistical significance.

RESULTS {#sec1-3}
=======

The reduction in PPD at 3 months was 32.79% and 42.62% at 9 months for group PRF. It was 33.33% and 43.86% at 3 and 9 months for group T-PRF. It was not statistically significant on intergroup comparison \[[Graph 1](#F21){ref-type="fig"} and [Table 1](#T1){ref-type="table"}\].

![Percentage change in probing pocket depth](JISP-23-554-g017){#F21}

###### 

Mean reduction and percentage change in probing pocket depth (mm) amongst study group

  PERIOD     GROUP PRF   GROUP T-PRF   UNPAIRED '*t*' TEST                   
  ---------- ----------- ------------- --------------------- ------- ------- -------
  3 MONTHS   2.00        32.79         1.90                  33.33   0.171   0.866
  9 MONTHS   2.60        42.62         2.50                  43.86   0.231   0.820

The reduction in RAL at 3 and 9 months was 31.15% and 40.98% for group PRF and 31.58% and 42.11% at 3 and 9 months for group T-PRF \[[Graph 2](#F22){ref-type="fig"} and [Table 2](#T2){ref-type="table"}\]. It was not statistically significant on intergroup comparison.

![Percentage change in relative attachment level](JISP-23-554-g018){#F22}

###### 

Mean reduction and percentage change in relative attachment level (ral) (mm) amongst study groups

  PERIOD     GROUP PRF   GROUP T-PRF   UNPAIRED '*t*' TEST                   
  ---------- ----------- ------------- --------------------- ------- ------- -------
  3 MONTHS   1.90        31.15         1.80                  31.58   0.172   0.866
  9 MONTHS   2.50        40.98         2.40                  42.11   0.176   0.862

The reduction in defect depth at 9 months was 26.23% for group PRF and 23.74% for group T-PRF which was not statistically significant \[[Graph 3](#F23){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\].

![Percentage change in defect depth](JISP-23-554-g019){#F23}

###### 

Mean reduction and percentage change in defect depth (mm) amongst study groups

  PERIOD     GROUP PRF   GROUP T-PRF   UNPAIRED '*t*' TEST                   
  ---------- ----------- ------------- --------------------- ------- ------- -------
  9 MONTHS   1.60        26.23         1.35                  23.74   0.778   0.447

In light microscopy, the PRF sample showed an organized network of fibers \[[Figure 17](#F17){ref-type="fig"}\]. In T-PRF, the sections showed a highly organized structure of fibrin and cellular components \[[Figure 18](#F18){ref-type="fig"}\]. Both the fibrin and cellular components appeared denser than PRF.

![The arrow shows light microscopic analysis of platelet-rich fibrin clot showing a highly organized network of fibers. The fibrin is prominent and highly distinguishable. Dense cellular components are also observed](JISP-23-554-g020){#F17}

![The arrow shows light microscopic analysis of titanium-prepared platelet-rich fibrin clot showing a well-organized structure of fibrin and cellular components. Both the fibrin and cellular components appeared denser and thicker as compared to platelet-rich fibrin](JISP-23-554-g021){#F18}

Scanning electron microscopy showed that PRF fibrin matrix appeared organized with line-like structures \[[Figure 19](#F19){ref-type="fig"}\] whereas T-PRF fibrin matrix appeared more organized, mature, and thicker \[[Figure 20](#F20){ref-type="fig"}\].

![The arrow shows scanning electron microscopic showing platelet-rich fibrin matrix as organized and mature line-like structures. The presence of both thin and thick fibrils are seen](JISP-23-554-g022){#F19}

![The arrow shows scanning electron microscopic showing titanium-prepared platelet-rich fibrin matrix as organized, mature, and thicker (arrow)](JISP-23-554-g023){#F20}

DISCUSSION {#sec1-4}
==========

There has not been any biomaterial which is considered as gold standard for the treatment of infrabony defects.\[[@ref18]\] Hence, there is always a quest for an ideal biomaterial. PRF has been the most vividly researched biomaterial and was first developed as a biomaterial in France in 2001.\[[@ref19]\]

There have been a lot of successful clinical trials that have been reported with PRF in regenerative treatment.\[[@ref10][@ref20]\] O'Connell\[[@ref20]\] in a study described that contact with silica particle could not be avoided. The tubes were coated with dense silica particles which would sediment with the RBCs, a minute portion of which were suspended colloidally in buffy coat, fibrin, and platelet poor plasma layers, and thus reach the patient.

Many authors have discussed the biocompatibility and hemocompatibility of titanium.\[[@ref21]\] Tunalı *et al.*\[[@ref11]\] in their study, found that the structure of PRF and T-PRF was very similar histologically. The fibrin clot of T-PRF was denser.\[[@ref11]\] PRF/T-PRF was used as a GTR membrane in the present study for the prevention of an epithelial migration.

In our study, the reduction in PPD in both the groups from baseline to 9 months was seen (intragroup comparison). On intergroup comparison, there was no statistically significant difference. This result is in accordance with Chatterjee *et al.*\[[@ref22]\] and Sharma and Pradeep.\[[@ref8]\]

In intragroup comparison, statistically significant gain in the attachment levels was seen at 3 and 9 months in control and the test groups. However, on intergroup comparison, there was no statistical difference. This was in accordance with a study conducted by Chatterjee *et al.*\[[@ref22]\]

PRF is a reservoir of growth factors and cytokines, has shown to decrease matrix metalloproteinases-8 and interleukin-1 β but increase in tissue inhibitor of metalloproteinases-1 levels, thereby promoting periodontal soft-tissue healing.\[[@ref23]\] It has also been reported that PRF induces a significant and continuous stimulation of proliferation in all cell types of the periodontium except epithelial cells.\[[@ref24]\]

Both the groups showed statistically significant reduction in the defect depth from baseline values to 9 months on intragroup comparisons which were similar to a study conducted by Chatterjee *et al.*\[[@ref22]\] Sharma and Pradeep.\[[@ref8]\] On intergroup comparisons, both the groups showed statistically insignificant mean and percentage change reduction.

This depth reduction can be attributed to the property of PRF.\[[@ref25]\] PRF stimulates the production of osteoprotegerin which in turn causes proliferation of osteoblasts.\[[@ref26]\]

Uneventful healing in patients was observed which was in agreement with another previous study by Sharma and Pradeep.\[[@ref8]\] Thus, supporting the fact that PRF enhances wound healing.

In light microscopy, T-PRF appears denser in both fibrin network and cellular components as compared to PRF. In scanning electron microscopy, T-PRF appears to show denser fibers and denser infiltration of cells indicating the presence of dense fibrin matrix.\[[@ref27]\] The histologic picture is in accordance with Tunalı *et al.*\[[@ref16]\]

CONCLUSION {#sec1-5}
==========

Results of the study show that both PRF and T-PRF are equally efficacious as regenerative material. However, T-PRF was more biocompatible as it did not contain silica particles and also histologically it had denser fibrin meshwork as compared to PRF which is giving it an added advantage over PRF. Further research with a bigger sample size is required to prove the clinical and histologic efficacy of T-PRF.
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